Lucas Ward
Stock Analyst at Ascendiant Capital
(1.05)
# 3,788
Out of 4,981 analysts
19
Total ratings
42.11%
Success rate
-21.18%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.2 → $6.5 | $3.47 | +87.32% | 4 | Sep 9, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $7 → $3 | $1.40 | +114.29% | 3 | Sep 3, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $3.4 → $3.6 | $2.40 | +50.00% | 5 | Jun 16, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.01 | +365.89% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.72 | +6,130.57% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.48 | +182,332.43% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $6.2 → $6.5
Current: $3.47
Upside: +87.32%
60 Degrees Pharmaceuticals
Sep 3, 2025
Maintains: Buy
Price Target: $7 → $3
Current: $1.40
Upside: +114.29%
LiqTech International
Jun 16, 2025
Maintains: Buy
Price Target: $3.4 → $3.6
Current: $2.40
Upside: +50.00%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.01
Upside: +365.89%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.72
Upside: +6,130.57%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.48
Upside: +182,332.43%